Waist circumference and migraine risk: headaches increase with waist circumference

Initial note: This article was originally published in the past and has been updated according to scientific and informative criteria. The purpose is informational: it does not replace medical advice. If you have health problems or persistent migraines, consult a healthcare professional.

IN BRIEF

• Numerous observational studies indicate a relationship between weight status (especially obesity) and increased frequency or severity of migraine.
• Abdominal obesity (measured by waist circumference) appears to be particularly associated with an increase in migraine morbidity in certain age groups.
• Biological plausibility includes systemic inflammation, adipokines, and metabolic alterations that can modulate the sensitivity of the trigeminal-vascular system.
• Some studies indicate that weight loss, including surgical weight loss, can reduce headache days and severity, but the evidence is not definitive for all patients.

Abstract: what does science say?

Migraine is a common and disabling neurological disorder. Research conducted over the past twenty years has observed that people who are overweight and, in particular, obese — and even more specifically with abdominal fat accumulation — report a higher frequency, severity, and probability of transformation to chronic forms of migraine compared to people of normal weight. The evidence comes mainly from observational studies and meta-analyses that show a moderate but consistent association: the relative risk is increased especially in women and younger age groups. Plausible mechanisms include the inflammatory state associated with adiposity, the production of hormones and adipokines (e.g., leptin, adiponectin), and metabolic and neurovascular alterations that can increase sensitivity to migraine triggers. Some weight loss interventions (behavioral or surgical) have shown improvements in the frequency and severity of attacks, but methodological limitations remain: most studies are observational, controls are variable, and it is not always possible to separate the effect of weight from concomitant behavioral or pharmacological changes. Therefore, the relationship should be interpreted with caution: there is plausibility and evidence of association, but not automatic proof of causality for all cases.

What it means in practice

For those living with migraine, research suggests that body weight status can influence the course of the disease. Recent meta-analyses show an increased risk of migraine in obese individuals compared to those of normal weight [1]. Population studies of tens of thousands of participants have shown that an increase in body mass index (BMI) is associated with a higher frequency of headache days and greater pain-related disability [2]. In particular, abdominal obesity — measured by waist circumference — has been associated with a higher probability of migraine in analyses controlled for age and sex [5]. From a clinical point of view, it is not possible to state that obesity is the sole cause of migraine, but epidemiological and biological data make it plausible that adipose tissue, through the production of cytokines and adipokines, can modulate inflammatory processes and the sensitivity of the trigeminal nociceptive system, favoring a higher frequency or severity of attacks [7][8]. Some weight loss interventions, including studies on patients undergoing bariatric surgery or intensive weight reduction programs, have reported reductions in headache days and severity, although the quality of the studies and the heterogeneity of the interventions limit clear conclusions [10]. In summary: the evidence supports that overweight and obesity (and sometimes more specifically central obesity) are factors associated with worse migraine outcomes in many people; this does not automatically imply that weight loss alone will resolve migraine for all patients, but it indicates that weight management can be considered part of a comprehensive approach to care, along with pharmacological therapies and lifestyle strategies supported by a healthcare professional [4][6].

KEY POINTS TO REMEMBER

• Obesity is associated with a moderate increase in the risk of migraine and a worsening of the frequency and severity of attacks in numerous observational studies.
• Abdominal fat accumulation shows specific associations with migraine patterns in some populations.
• There is biological plausibility (inflammation, adipokines, metabolism) that makes the observed association consistent.
• Weight loss can improve migraine in some studies, but the evidence is not uniform and does not replace personalized medical therapy.

Limitations of the evidence

Observational studies vs. causal evidence

Most of the available information comes from observational studies (cross-sectional or cohort) and meta-analyses of these studies. These designs can document associations but cannot establish an incontrovertible cause-and-effect relationship: confounding factors (e.g., physical activity, depression, weight-influencing drugs) can affect both weight and migraine frequency [6].

Measures of adiposity and methodological variability

The definition of obesity varies: many studies use self-reported BMI, others measure waist circumference or body composition. BMI does not distinguish between fat mass and lean mass; fat distribution (visceral vs. subcutaneous) may be more relevant for the inflammatory and metabolic mechanisms involved in migraine [5][1].

Effect of age, sex, and other variables

The association appears more pronounced in women and younger age groups in some studies; furthermore, the use of preventive medications (some of which increase weight) or the presence of metabolic comorbidities can modify the results [4][1].

Weight loss interventions: partial evidence

Some studies (including meta-analyses on the effect of bariatric surgery or intensive programs) report reductions in the frequency and severity of attacks after weight loss, but the studies often lack randomized controls, have small samples, or short follow-up: thus, a degree of uncertainty remains about who benefits and how long the effect lasts [10].

Editorial conclusion

Current scientific evidence paints a consistent picture: there is an association between overweight/obesity — and in more cases between abdominal obesity — and a worse course of migraine in terms of frequency and severity. Biological plausibility is supported by studies that link adipose tissue to inflammatory processes, adipokines, and neuropeptides relevant to migraine pathophysiology. However, the methodological limitations of the available studies do not allow the message to be reduced to a universal rule or a single definitive intervention for all patients. For those suffering from migraine, a personalized clinical evaluation that considers weight, metabolic comorbidities, medications in use, and individual preferences remains the correct approach; any weight interventions must be discussed and followed by healthcare professionals. Future research, particularly well-conducted prospective studies and trials on targeted weight interventions, is needed to better define if and how weight management can become a standard component of migraine care.

Editorial note: The article has been updated to reflect the most recent systematic reviews and meta-analyses available. The content is for informational purposes only and does not replace specialized medical advice.

SCIENTIFIC RESEARCH

1. Gelaye B, Sacco S, Brown WJ, Nitchie HL, Ornello R, Peterlin BL. Body composition status and the risk of migraine: a meta-analysis. Neurology. 2017 May 9;88(19):1795–1804. https://doi.org/10.1212/WNL.0000000000003919
2. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: A population study. Neurology. 2006 Feb;66(4):545–550. https://doi.org/10.1212/01.wnl.0000197218.05284.82
3. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006 Jul;67(2):252–257. https://doi.org/10.1212/01.wnl.0000225052.35019.f9
4. Ornello R, Ripa P, Pistoia F, Degan D, Tiseo C, Carolei A, Sacco S. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies. J Headache Pain. 2015 Mar 28;16:27. https://doi.org/10.1186/s10194-015-0510-z
5. Santos IS, Goulart AC, Passos VM, del Carmen Molina M, Lotufo PA, Bensenor IM. Obesity, abdominal obesity and migraine: a cross-sectional analysis of ELSA-Brasil baseline data. Cephalalgia. 2015;35(5):426–436. https://doi.org/10.1177/0333102414544978
6. Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL. Obesity and headache: Part I—A systematic review of the epidemiology of obesity and headache. Headache. 2014 Feb;54(2):219–234. https://doi.org/10.1111/head.12296
7. Rivera-Mancilla E, Al‑Hassany L, Villalón CM, MaassenVanDenBrink A. Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus. Front Neurol. 2021 Jun 9;12:686398. https://doi.org/10.3389/fneur.2021.686398
8. Leptin, adiponectin and resistin blood adipokine levels in migraineurs: Systematic reviews and meta-analyses. Cephalalgia. 2019;39(7):1010–1021. https://doi.org/10.1177/0333102418807182
9. Domínguez C, Vieites-Prado A, Pérez‑Mato M, Sobrino T, Rodríguez‑Osorio X, López A, et al. Role of adipocytokines in the pathophysiology of migraine: A cross-sectional study. Cephalalgia. 2018;38(9):1649–1659. https://doi.org/10.1177/0333102417720213
10. Domínguez C, et al. Effects of Surgical and Non-surgical Weight Loss on Migraine Headache: a Systematic Review and Meta-Analysis. Obes Surg. 2020 Jun;30(6):2173–2185. https://doi.org/10.1007/s11695-020-04429-z

Note: if some bibliographic references or specific details were missing in this text, placeholders indicated in square brackets [ ] have been left.